Vazquez N, Lee C, Valenzuela I, Phan TP, Derderian C, Chávez M, Mooney NA, Demeter J, Aziz-Zanjani MO, Cusco I, Codina M, Martínez-Gil N, Valverde D, Solarat C, Bruel AL, Thauvin-Robinet C, Steichen E, Filges I, Joset P, De Geyter J, Vaidyanathan K, Gardner TP, Toriyama M, Marcotte EM, Drew K, Roberson EC, Jackson PK, Reiter JF, Tizzano EF, Wallingford JB
The human ciliopathy protein RSG1 links the CPLANE complex to transition zone architecture
Nat Commun. 2025 Jul 1;16(1):5701
DOI: 10.1038/s41467-025-61005-8
IF: 15.7
RESEARCH GROUPS
Genetics Medicine
Number of publications
% Q1
% D1
% Leadership
% Female Leadership
CROWN (2021-2025)
HCP10% (2021-2025)
% Open access
% International Collaboration
Highly cited papers / HCP 1% (2021-2025)
Publications in high-IF journals with high Altmetric scores
Number of Ongoing Projectes (total)
International ongoing projects
Number of New projects (total)
International new projects
Number of Active clinical Trials
Number of New Clinical Trials
Number of Theses
CORE/MISSIONS
PROGRAMS
TEAM
Group Leader
Miguel del Campo Casanelles
Principal Investigator (PI)
Miguel del Campo Casanelles
Researchers
Anna Maria Cueto Gonzalez, Amaia Lasa Aranzasti, Berta Campos Estela, Lidia Carreno Gago, Marta Codina Solà, Mar Costa Roger, Joanna Domenech Vivo, Jordi Leno Colorado, Emma Lorente Ruiz, Alejandro Moles Fernandez, Nuria Martinez Gil, Marina Viñas Jornet, Hector San Nicolas Fernandez
PhD Students
Laura Trujillano Lidon, Irene Valenzuela Palafoll, Cristina Cea Arestin, Paula Fernandez Alvarez, Mar Xuncla Lloret
SELECTED PUBLICATIONS
Codina-Solà M, Costa-Roger M, Abulí A, Blasco-Pérez L, Martínez-Cruz D, Leno-Colorado J, Sánchez-Duran MA, Arévalo S, Maiz N, Gómez-Andres D, Vázquez E, Rodó C, Tizzano EF
Type 0 Spinal Muscular Atrophy Detected by Prenatal Exome Sequencing: Towards a Recognizable Fetal Phenotype
Prenat Diagn. 2026 Feb;46(2):290-294
DOI: 10.1002/pd.70041
IF: 2.7
Valenzuela I, Codina-Solà M, Vazquez E, Cueto-González A, Leno-Colorado J, Lasa-Aranzasti A, Trujillano L, Masotto B, Masas M, Escobar M, García-Arumí E, Tizzano EF
Deep phenotyping of 11 individuals with pathogenic variants in RNU4-2 reveals a clinically recognizable syndrome
Genet Med. 2026 Jan;28(1):101633
DOI: 10.1016/j.gim.2025.101633
IF: 6.2
Trujillano L, Valenzuela I, Costa-Roger M, Cuscó I, Fernandez-Alvarez P, Cueto-González A, Lasa-Aranzasti A, Masotto B, Abulí A, Codina-Solà M, Del Campo M, Ruiz Moreno JA, Pardo Domínguez C, Palma Milla C, Pérez de la Fuente R, Quesada-Espinosa JF, Núñez-Enamorado N, Gener B, Ballesta-Martínez MJ, Brea-Fernández AJ, Fernández-Prieto M, Trujillo-Quintero JP, Ruiz A, Santos-Simarro F, Rosello M, Orellana C, Martinez F, Martinez-Monseny AF, Casas-Alba D, Serrano M, Palomares-Bralo M, Rikeros-Orozco E, Gómez-Cano MÁ, Tirado-Requero P, Pié Juste J, Ramos FJ, García-Arumí E, Tizzano EF
Comprehensive Clinical and Genetic Characterization of a Spanish Cohort of 22 Patients With Bainbridge-Ropers Syndrome
Clin Genet. 2025 Jun;107(6):646-662
DOI: 10.1111/cge.14701
IF: 2.3
Barbero AIS, Valenzuela I, Fernández-Alvarez P, Vazquez É, Cueto-Gonzalez AM, Lasa-Aranzasti A, Trujillano L, Masotto B, Arumí EG, Tizzano EF
New Insights Into the Spectrum of RASopathies: Clinical and Genetic Data in a Cohort of 121 Spanish Patients
Am J Med Genet A. 2025 Mar;197(3):e63905
DOI: 10.1002/ajmg.a.63905
IF: 1.7
SELECTED PROJECTS
Trio Study in Fetuses with Central Nervous System Malformations
Principal Investigator: Carlota Rodó
Agency: Fundació La Marató de TV3
Funding: 197,000 €
Period: 20/02/2025 - 19/02/2028
Paving the Way for Personalized Medicine in neonatal and pediatric Intensive Care Units
Principal Investigator: Fernando Santos Simarro and Maria Palomares Bralo
Agency: ISCIII
Funding: 147,620 €
Period: 2022-2025 (until 2027)
Whole genome sequencing as the first test to improve the genetic diagnosis of hereditary breast/ovarian cancer
Principal Investigator: Sara Gutiérrez-Enríquez
Agency: Carlos III Health Institute
Funding: 220,220 €
Period: 2023-2025
PRISMA-II: Risk stratification of breast/ovarian cancer using the polygenic risk score. Validation in carriers, prospective cohort, and feasibility of genome sequencing
Principal Investigator: Judith Balmaña
Agency: Carlos III Health Institute
Funding: 190,000 €
Period: 2024 - 2026
PATENTS
DISSEMINATION ACTIVITIES